Parkinson's disease | pharmaphorum

Monday 8 July 2024

Channels

Content type

Categories

Categories

Sort by

Order

Parkinson's disease

News

astrazeneca-sign

AZ to develop Parkinson's drug with Takeda

AstraZeneca could receive up to $400 million from Takeda after approaching the company to jointly develop and market a new treatment for Parkinson’s disease (PD).

News

FDA approve Rituxan

First new Parkinson's treatment in decade gains US approval

Newron's Xadago, a new add-on treatment for patients with Parkinson's disease, has been approved by the FDA.

News

SITraN

Groundbreaking ‘virtual biotech’ Keapstone Therapeutics laun...

Parkinson’s UK and the University of Sheffield have launched a groundbreaking ‘virtual biotech’ company to develop new treatments for Parkinson’s disease.

News

x-ray image of human head with brain and electric pulses

NHS-funded Parkinson's app improves meds adherence

uMotif app significantly improves adherence, quality of clinical consultation.

News

digital illustration neurons

Allergan negotiates option to buy neurology biotech

Allergan to co-develop Parkinson's drug with Lysosomal Therapeutics

Views & Analysis

Apple-building

Digital Health Round-up – Apple's cautious approach to healt...

A round-up of this week’s top digital healthcare news. Marco Ricci reports.